![](https://www.diabetesnews.com/wp-content/uploads/2012/09/drug_research_1-150x150.jpg)
A study carried out in India examining the safety and efficacy of self-donated (autologous), transplanted bone marrow stem cells in patients with type 2 diabetes (TD2M), has found that patients receiving the transplants, when compared to a control group of TD2M patients who did not receive transplantation, required less insulin post-transplantation.
Read more